Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Serine is the major residue for ADP-ribosylation upon DNA damage

Palazzo, L., Leidecker, O., Prokhorova, E., Dauben, H., Matić, I., & Ahel, I. (2018). Serine is the major residue for ADP-ribosylation upon DNA damage. Elife, 7. doi:10.7554/eLife.34334.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:
ausblenden:
externe Referenz:
https://www.ncbi.nlm.nih.gov/pubmed/29480802 (beliebiger Volltext)
Beschreibung:
-
OA-Status:
Keine Angabe

Urheber

einblenden:
ausblenden:
 Urheber:
Palazzo, L., Autor
Leidecker, O.1, Autor           
Prokhorova, E., Autor
Dauben, H.1, Autor           
Matić, I.1, Autor           
Ahel, I., Autor
Affiliations:
1Matic – ADP-ribosylation in DNA Repair and Ageing, Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society, ou_1942299              

Inhalt

einblenden:
ausblenden:
Schlagwörter: biochemistry chemical biology human
 Zusammenfassung: PARPs are a family of enzymes that synthesise ADP-ribosylation (ADPr), a reversible modification of proteins that regulates many different cellular processes. Several mammalian PARPs are known to regulate the DNA damage response, but it is not clear which amino acids in proteins are the primary ADPr targets. Previously we reported that ARH3 reverses the newly discovered type of ADPr (ADPr on serine residues; Ser-ADPr) and developed tools to analyse this modification (Fontana et al, 2017). Here we show that Ser-ADPr represents the major fraction of ADPr synthesised after DNA damage in mammalian cells and that globally Ser-ADPr is dependent on HPF1, PARP1 and ARH3. In the absence of HPF1, glutamate/aspartate become the main target residues for ADPr. Furthermore, we describe a method for site-specific validation of serine ADP-ribosylated substrates in cells. Our study establishes serine as the primary form of ADPr in DNA damage signalling.

Details

einblenden:
ausblenden:
Sprache(n):
 Datum: 2018-02-262018
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: Anderer: 29480802
DOI: 10.7554/eLife.34334
ISSN: 2050-084X (Electronic)2050-084X (Linking)
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Elife
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 7 Artikelnummer: - Start- / Endseite: - Identifikator: -